Researchers from DTU, Cambridge, and Costa Rica have cracked the code to produce experimental snakebite antivenoms based on human antibodies. Antivenoms based on human antibodies have the potential of enhancing the quality of snakebite envenoming treatment considerably, avoiding the severe and in rare cases lethal side effects that current antivenoms based on antibodies from horses can cause.
